Page 229 - FINAL PROGRAMME 2017

P-301 Uterine Natural Killer Cell Phenotype: Predicting ART (Assisted Reproductive Technology) success in endometriosis-associated infertility.
L. Glover1, D. Crosby1, U. Thiruchelvam2, C. Ni Chorcora2, C. O'Farrelly2, M. Wing eld1,3 1Merrion Fertility Clinic, National Maternity Hospital, Dublin, Ireland
2Trinity Biomedical Sciences Institute- Trinity College Dublin, Medicine, Dublin, Ireland 3University College Dublin, Obstetrics and Gynaecology, Dublin, Ireland
P-302 Differential transcript pro le of cumulus cells of infertile women with and without advanced endometriosis who underwent ovarian stimulation
C.M. Luz1, J. Meola1, M.G. Da Broi1, L.F.I. Silva1, J.R. Plaça2, W.A. Silva Jr2, R.A. Ferriani1, P.A. Navarro1
1Human Reproduction Division- Ribeirao Preto School of Medicine- University of São Paulo, Obstetrics and Gynecology, Ribeirão Preto, Brazil
2Ribeirao Preto School of Medicine- University of São Paulo, Laboratory of Molecular Genetics and Bioinformatics, Ribeirão Preto, Brazil
P-303 Speci c biopsychosocial variables affect sexual function in endometriosis patients
N. Pluchino1, S. Shabanov1, R. Marci1, J.M. Wenger1
1Hopital Universitaire de Genève, Ob/Gyn, Geneva, Switzerland
P-304 Ef cacy of preimplantation genetic screening (PGS) for successful pregnancy in infertile, endometrioma patients
S.J. Chon1, Y.J. Lee1
1Gil hospital, Obstetrics and Gynecology, Incheon-si, Korea- South
P-305 The cytokines analysis suggest the immune system activity in endometriosis
A. Turienzo Diez1, A. Fabregat Reolid2, B. Moliner Renau3, B. Lledó Bosch2, J. Llácer Aparicio3, R. Bernabeu Perez3
1Instituto Bernabeu, IB Biotech, Alicante, Spain 2Instituto Bernabeu, Biotech, Alicante, Spain 3Instituto Bernabeu, Clinical, Alicante, Spain
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 229
POSTERS